FDA Warns Against Esbelta Intense Loss Due to Hidden Harmful Ingredients
On August 18, 2026, the Food and Drug Administration (FDA) cautioned consumers against purchasing or using Esbelta Intense Loss, a weight-loss product marketed on various websites, including www.elegantfigure.com, and potentially available in retail stores. The FDA's laboratory analysis revealed that Esbelta Intense Loss contains several undisclosed ingredients, specifically sibutramine, desmethylsibutramine, benzylsibutramine, and sildenafil, which were not listed on the product label.
Sibutramine is a controlled substance that was previously removed from the market due to safety concerns related to its effects on blood pressure and heart rate. The presence of desmethylsibutramine and benzylsibutramine, which are structurally similar to sibutramine, raises further safety alarms as they are known to significantly increase blood pressure and heart rate, posing serious risks for individuals with a history of heart disease, heart failure, irregular heartbeat, or stroke.
Additionally, the product contains sildenafil, the active ingredient in the FDA-approved medication Viagra, which is used to treat erectile dysfunction. This ingredient can interact dangerously with nitrates found in some prescription medications, such as nitroglycerin, potentially leading to a dangerous drop in blood pressure. This is particularly concerning for individuals with diabetes, high blood pressure, high cholesterol, or heart disease, who may be prescribed nitrate medications.
The FDA emphasizes that both healthcare professionals and consumers should report any adverse events or side effects associated with the use of Esbelta Intense Loss to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program. This notification serves as a reminder to the public about the risks associated with products marketed as dietary supplements or conventional foods that may contain hidden harmful ingredients. Such products are often promoted for weight loss, sexual enhancement, pain relief, and bodybuilding, and are misleadingly represented as all-natural. Consumers are urged to exercise caution when considering these products, as the FDA cannot test every dietary supplement for harmful hidden ingredients.
In summary, the FDA's warning highlights the potential dangers of using Esbelta Intense Loss, underscoring the importance of consumer awareness regarding the safety of weight-loss products and the need for transparency in labeling.




